# Biotechnology

About 22 search results

Sort by Date

GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million

BIOHK2026 (Hong Kong International Biotechnology Conference and Exhibition), 9-12 September, Hong Kong - Connecting Global Leaders in Biotechnology

Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases

METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager

Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence

NextRise 2026, Seoul Successfully Wraps Up as Asia's Leading Startup Fair Co-hosted by KITA and KDB

Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership

Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications

ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing

Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

Seoul National University Hospital to Expand Global K-Bio Collaboration at BIO USA 2026

Angel Yeast Chairman Reflects on 40 Years of Bringing Yeast to Millions of Households Worldwide

Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health

Peer-reviewed publication shows that Lateral pharma's SCP drugs for neuropathic pain act via the novel target LanCL1

Xinhua Silk Road: Longkou-based apple cider vinegar producer shares experiences with overseas visitors

NYB.AI Launches Vecura 2.0, Bringing Agentic AI Workflows to Molecular Discovery, with NVIDIA

Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration

Driving Innovation, Empowering Partners: ACROBiosystems Showcases Comprehensive CGT Solutions Anchored by GMP Capabilities at Bio Korea 2026

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

Academia Sinica Academician Chen Pei-jer, speaking in an interview with The Storm Media, said gene editing has formally ushered in a new clinical era of xenotransplantation. (Photo by Apple Chang))

Exclusive | Taiwan Could Lose Organ Transplant Independence to China Within a Decade, Top Scientist Warns

About Storm Media

The Storm Media (world.storm.mg) is dedicated to bringing Taiwan's voice to the world. We deliver timely, balanced, and internationally oriented reporting and in-depth analysis on key issues including democratic politics, cross-strait relations, geopolitics, Indo-Pacific strategy, technology industry, and economic trends — helping global readers gain a deeper understanding of Taiwan and the Asia-Pacific region.

The Storm Media (Chinese)

The Storm Media Japan

The Journalist

1% STYLE

Neihu District, Ruiguang Road, Lane 513, No. 37, 4F. Taipei, 114.

Stay True・Look Beyond

Version: 20260716-085450